Shuttle Pharmaceuticals Enters Material Definitive Agreement
Ticker: SHPH · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, 8-k
TL;DR
Shuttle Pharma just signed a big deal, filing an 8-K to confirm.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. announced on April 3, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Gaithersburg, MD, filed this Form 8-K to report this significant event.
Why It Matters
This filing indicates a significant development for Shuttle Pharmaceuticals, likely involving a new contract, partnership, or acquisition that could impact its future operations and stock value.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks depending on the nature of the agreement, which is not detailed in this initial filing.
Key Numbers
- 001-41488 — SEC File Number (Identifies the company's filing history with the SEC.)
- 82-5089826 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
- April 3, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Shuttle Pharmaceuticals?
The filing does not specify the details of the material definitive agreement, only that one has been entered into as of April 3, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 3, 2025.
What is Shuttle Pharmaceuticals Holdings, Inc.'s principal executive office address?
The principal executive offices of Shuttle Pharmaceuticals Holdings, Inc. are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
Under which section of the Securities Exchange Act is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the Standard Industrial Classification code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification code for Shuttle Pharmaceuticals Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).